LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS

被引：0
|
作者：
Ligthelm, R. [1 ]
Christensen, T. E. [2 ]
Thomsen, T. L. [2 ]
Yang, W. [3 ]
机构：
[1] EHM, Hoofddorp, Netherlands
[2] Novo Nordisk AS, Virum, Denmark
[3] China Japan Friendship Hosp, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74982-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A402 / A402
页数：1
相关论文
共 50 条
  • [1] Switching from biphasic human insulin to biphasic insulin aspart 30 in type 2 diabetes: Results from the ASEAN subgroup of the A1chieve study
    Hussein, Zanariah
    Lim-Abrahan, Mary Anne
    Jain, Anand B.
    Goh, Su Yen
    Soewondo, Pradana
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S24 - S29
  • [2] IMPROVE (TM) observational study of biphasic insulin aspart 30/70 in patients with Type 2 diabetes mellitus
    Kawamori, Ryuzo
    Valensi, Paul
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 507 - 516
  • [3] SHORT AND LONG-TERM COST-EFFECTIVENESS OF SWITCHING THERAPY FROM BIPHASIC HUMAN INSULIN 30 TO BIPHASIC INSULIN ASPART 30 IN PEOPLE WITH TYPE-2 DIABETES
    Home, P. D.
    Soewondo, P.
    Hussein, Z.
    Shafie, A. A.
    AlRaddady, K.
    Baadbad, R.
    Hammerby, E.
    Nikolajsen, A.
    Andersen, M. F. B.
    Henriksen, O.
    VALUE IN HEALTH, 2013, 16 (03) : A164 - A164
  • [4] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results
    Nobels, Frank
    D'Hooge, Dirk
    Crenier, Laurent
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1017 - 1026
  • [5] Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study
    Shah, S.
    Benroubi, M.
    Borzi, V.
    Gumprecht, J.
    Kawamori, R.
    Shaban, J.
    Shestakova, M.
    Wenying, Y.
    Valensi, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 574 - 582
  • [6] COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING
    Suchankova, E.
    Dolezal, T.
    Pisarikova, Z.
    Rychna, K.
    Bartaskova, D.
    VALUE IN HEALTH, 2009, 12 (07) : A405 - A406
  • [7] Treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients: long-term effects on diabetesrelated complications
    Lammert, M
    Palmer, AJ
    Roze, S
    Valentine, WJ
    DIABETOLOGIA, 2005, 48 : A308 - A309
  • [8] Improvement in Metabolic Control in Type 2 Diabetic Patients after Switching from Biphasic Human Insulin to Biphasic Insulin Aspart 30/70: An Observational Study in Hungary
    Geroe, Laszlo
    Gyimesi, Andras
    Hidvegi, Tibor
    DIABETES, 2009, 58 : A527 - A527
  • [9] Switching patients from human premix insulin to biphasic insulin aspart 30 leads to improved glycaemic control: a subgroup analysis of Korean patients with Type 2 diabetes in the PRESENT study
    Oh, Seung Joon
    Kim, Jong Hwa
    Park, Suk O.
    Son, Suk Man
    Song, Sun Kyung
    Lee, So Ra
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S65 - S65
  • [10] Biphasic insulin aspart and biphasic human insulin in type 2 diabetes: A comparison
    Jacobsen, LV
    Bell, PM
    McSorely, P
    Kristensen, A
    DIABETES, 2000, 49 : A112 - A112
12345